These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
380 related items for PubMed ID: 7793300
21. A comparison of the effects of three luteal phase support protocols with estrogen on in vitro fertilization-embryo transfer outcomes in patients on a GnRH antagonist protocol. Scheffer JB, Scheffer BB, Carvalho RF, Aguiar AP, Lozano DHM, Labrosse J, Grynberg M. JBRA Assist Reprod; 2019 Aug 22; 23(3):239-245. PubMed ID: 30875186 [Abstract] [Full Text] [Related]
22. Luteal phase hormonal profile in prediction of pregnancy outcome after assisted reproduction. Vicdan K, Zeki Isik A. Eur J Obstet Gynecol Reprod Biol; 2001 May 22; 96(1):98-101. PubMed ID: 11311769 [Abstract] [Full Text] [Related]
23. Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analogue and HMG. Smitz J, Devroey P, Braeckmans P, Camus M, Khan I, Staessen C, Van Waesberghe L, Wisanto A, Van Steirteghem AC. Hum Reprod; 1987 May 22; 2(4):309-14. PubMed ID: 3114314 [Abstract] [Full Text] [Related]
24. The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT. Smitz J, Devroey P, Camus M, Deschacht J, Khan I, Staessen C, Van Waesberghe L, Wisanto A, Van Steirteghem AC. Hum Reprod; 1988 Jul 22; 3(5):585-90. PubMed ID: 3139698 [Abstract] [Full Text] [Related]
25. Human chorionic gonadotrophin is a better luteal support than progesterone in ultrashort gonadotrophin-releasing hormone agonist/menotrophin in-vitro fertilization cycles. Golan A, Herman A, Soffer Y, Bukovsky I, Caspi E, Ron-El R. Hum Reprod; 1993 Sep 22; 8(9):1372-5. PubMed ID: 8253920 [Abstract] [Full Text] [Related]
26. Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins. Herman A, Ron-El R, Golan A, Raziel A, Soffer Y, Caspi E. Fertil Steril; 1990 Jan 22; 53(1):92-6. PubMed ID: 2104811 [Abstract] [Full Text] [Related]
27. Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in in vitro fertilization. Segal S, Casper RF. Fertil Steril; 1992 Jun 22; 57(6):1254-8. PubMed ID: 1601147 [Abstract] [Full Text] [Related]
30. Ratio of oestradiol concentration on the day of human chorionic gonadotrophin administration to mid-luteal oestradiol concentration is predictive of in-vitro fertilization outcome. Sharara FI, McClamrock HD. Hum Reprod; 1999 Nov 22; 14(11):2777-82. PubMed ID: 10548621 [Abstract] [Full Text] [Related]
31. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization. Garcia JE, Padilla SL, Bayati J, Baramki TA. Fertil Steril; 1990 Feb 22; 53(2):302-5. PubMed ID: 2105247 [Abstract] [Full Text] [Related]
32. A prospective randomized comparison of routine buserelin acetate and a decreasing dosage of nafarelin acetate with a low-dose gonadotropin-releasing hormone agonist protocol for in vitro fertilization and intracytoplasmic sperm injection. Takeuchi S, Minoura H, Shibahara T, Tsuiki Y, Noritaka F, Toyoda N. Fertil Steril; 2001 Sep 22; 76(3):532-7. PubMed ID: 11532477 [Abstract] [Full Text] [Related]
33. GnRH agonist treatment of luteal phase deficiency in HCG-triggered IVF cycles: a matched case-control study. Mendoza-Tesarik R, Mendoza N, López CC, Tesarik J. Reprod Biomed Online; 2019 Aug 22; 39(2):225-230. PubMed ID: 31178369 [Abstract] [Full Text] [Related]
34. Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist. Younis JS, Matilsky M, Radin O, Ben-Ami M. Fertil Steril; 2001 Aug 22; 76(2):294-9. PubMed ID: 11476775 [Abstract] [Full Text] [Related]
35. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study. Pirard C, Donnez J, Loumaye E. Hum Reprod; 2006 Jul 22; 21(7):1894-900. PubMed ID: 16556673 [Abstract] [Full Text] [Related]
36. Regulation of ovarian follicular and luteal function during treatment with exogenous gonadotropins in anovulatory infertility. Yuen BH, Sy L, Cannon W. Am J Obstet Gynecol; 1981 Jul 15; 140(6):629-35. PubMed ID: 6167169 [Abstract] [Full Text] [Related]
37. Luteal phase characteristics following GnRH antagonist or agonist treatment - a comparative study. Friedler S, Gilboa S, Schachter M, Raziel A, Strassburger D, Ron El R. Reprod Biomed Online; 2006 Jan 15; 12(1):27-32. PubMed ID: 16454930 [Abstract] [Full Text] [Related]
38. The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation with progesterone or progesterone and estradiol. Fatemi HM, Camus M, Kolibianakis EM, Tournaye H, Papanikolaou EG, Donoso P, Devroey P. Fertil Steril; 2007 Mar 15; 87(3):504-8. PubMed ID: 17140572 [Abstract] [Full Text] [Related]
39. The luteal phase during gonadotropin therapy: effects of two human chorionic gonadotropin regimens. Grazi RV, Taney FH, Gagliardi CL, Von Hagen S, Weiss G, Schmidt CL. Fertil Steril; 1991 Jun 15; 55(6):1088-92. PubMed ID: 1903727 [Abstract] [Full Text] [Related]
40. A prospective randomized study on oestradiol valerate supplementation in addition to intravaginal micronized progesterone in buserelin and HMG induced superovulation. Smitz J, Bourgain C, Van Waesberghe L, Camus M, Devroey P, Van Steirteghem AC. Hum Reprod; 1993 Jan 15; 8(1):40-5. PubMed ID: 8458924 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]